The environmental and genetic evidence for the association of hyperlipidemia and hypertension

被引:52
作者
Yin Ruixing [1 ]
Wu Jinzhen [1 ]
Lin Weixiong [2 ]
Chen Yuming [1 ]
Yang Dezhai [2 ]
Pan Shangling [3 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Dept Cardiol, Nanning 530021, Guangxi, Peoples R China
[2] Guangxi Med Univ, Dept Mol Biol, Med Sci Res Ctr, Nanning 530021, Guangxi, Peoples R China
[3] Guangxi Med Univ, Sch Premed Sci, Dept Pathophysiol, Nanning 530021, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
blood pressure; genetic polymorphisms; hyperlipidemia; hypertension; lipids; risk factors; APOLIPOPROTEIN-E GENE; LIPOPROTEIN-LIPASE GENE; BLOOD-PRESSURE LEVELS; DYSLIPIDEMIC HYPERTENSION; METABOLIC SYNDROME; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; EPSILON-4; ALLELE; LDL CHOLESTEROL;
D O I
10.1097/HJH.0b013e32831bc74d
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Both hyperlipidemia and hypertension are the risk factors for coronary heart disease. Although studies have shown that there is an association between plasma lipid and blood pressure levels, the association of hyperlipidemia and hypertension is still not well established. The present study was undertaken to compare the differences in several environmental and genetic factors between hyperlipidemia and hypertension in the Guangxi Hei Yi Zhuang population. Methods A total of 1669 participants were surveyed by a stratified randomized cluster sampling. Information on environmental factors was collected with standardized questionnaires. Genotyping of angiotensin-converting enzyme, angiotensinogen, angiotensin receptor 2, apolipoprotein (apo) A-I, apoB, apoE, cholesteryl ester transfer protein, G-protein beta-3 subunit, hepatic lipase, lipoprotein lipase, microsomal triglyceride transfer protein, regulator of G-protein signaling 2, and sterol regulatory element-binding protein-2 was also performed. Results There were 358 (21.45%) participants with isolated hyperlipidemia, 257 (15.40%) with isolated hypertension, 189 (11.32%) with both conditions, and 865 (51.83%) normals. Hyperlipidemia was positively correlated with age, BMI, alcohol consumption, total energy and total fat intake, apoE, and microsomal triglyceride transfer protein genotypes, and negatively associated with total dietary fiber intake, apoA-I, and lipoprotein lipase genotypes. Hypertension was positively correlated with male sex, age, hyperlipidemia, total energy, total fat, and sodium intake, apoE, angiotensin receptor 2, and microsomal triglyceride transfer protein genotypes, and negatively associated with education level, total dietary fiber intake, angiotensin-converting enzyme, apoA-I, and lipoprotein lipase genotypes. Conclusion These findings suggest that hyperlipidemia and hypertension have many common risk factors. Hyperlipidemia is associated with hypertension in many aspects. J Hypertens 27:251-258 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 71 条
  • [1] Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p
    Allayee, H
    de Bruin, TWA
    Dominguez, KM
    Cheng, LSC
    Ipp, E
    Cantor, RM
    Krass, KL
    Keulen, ETP
    Aouizerat, BE
    Lusis, AJ
    Rotter, JI
    [J]. HYPERTENSION, 2001, 38 (04) : 773 - 778
  • [2] CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY
    ANDERSON, KM
    CASTELLI, WP
    LEVY, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16): : 2176 - 2180
  • [3] [Anonymous], 2002, CHIN J EPIDEMIOL
  • [4] The combination of ApoCIII, hepatic lipase and hormono sensitive lipase gene polymorphisms suggests an association with susceptibility to gestational hypertension
    Bernard, Nathalie
    Girouard, Joel
    Forest, Jean-Claude
    Giguere, Yves
    [J]. JOURNAL OF HUMAN GENETICS, 2007, 52 (03) : 244 - 254
  • [5] Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the Southeastern United States, Part II: Treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome
    Bestermann, W
    Houston, MC
    Basile, J
    Egan, B
    Ferrario, CM
    Lackland, D
    Hawkins, RG
    Reed, J
    Rogers, P
    Wise, D
    Moore, MA
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (06) : 292 - 305
  • [6] Bhavani A B, 2005, Indian Heart J, V57, P151
  • [7] Biscevic Azar, 2005, Med Arh, V59, P94
  • [8] Apolipoprotein E polymorphism and preclinical carotid artery disease in untreated hypertensive men
    Bleil, ME
    Ferrell, RE
    Sutton-Tyrrell, K
    Muldoon, MF
    Manuck, SB
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2006, 13 (01): : 98 - 100
  • [9] Brock Cori M., 2005, Metabolic Syndrome and Related Disorders, V3, P60, DOI 10.1089/met.2005.3.60
  • [10] A POPULATION AT RISK - PREVALENCE OF HIGH CHOLESTEROL LEVELS IN HYPERTENSIVE PATIENTS IN THE FRAMINGHAM-STUDY
    CASTELLI, WP
    ANDERSON, K
    [J]. AMERICAN JOURNAL OF MEDICINE, 1986, 80 (2A) : 23 - 32